⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
prnewswire.com
RDHL
ABBV
GILD
Dornan Engineering Group expands Executive Leadership Team with four Divisional Managing Directors USA - English USA - español USA - Français USA - English USA - Deutsch
prnewswire.com
CHTR
AMZN
GOOG
MSFT
IBM
VRTX
GILD
AMGN
T
VZ
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
globenewswire.com
ONCY
AGEN
CRDF
EXEL
GILD
Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study, STARt-002, at the 2025 San Antonio Breast Cancer Symposium
prnewswire.com
GILD
MGTX
CGTN: How does China set tone for economic work in 2026? USA - English USA - English Korea - 한국어
prnewswire.com
BABA
JD
NTES
PDD
BIDU
XPEV
NIO
LI
BYD
AMC
CMG
MCD
SBUX
YUM
COKE
PEP
KHC
MDLZ
COST
WMT
AMZN
GOOG
MSFT
NVDA
INTC
AMD
QCOM
TSM
MU
AAPL
MS
JPM
GS
BAC
WFC
C
V
MA
AXP
BBY
HD
LOW
TJX
ROST
ULTA
LULU
NKE
UA
PVH
RL
HOG
GM
F
STLA
TM
HON
GE
CAT
DE
IBM
ORCL
SAP
CRM
ADBE
NFLX
DIS
CMCSA
VZ
T
TMUS
CHTR
SIRI
PFE
JNJ
MRK
ABBV
BMY
GILD
AMGN
LLY
BIIB
REGN
VRTX
XOM
CVX
SHEL
TTE
COP
MPC
VLO
ET
KMI
NEE
DUK
SO
EXC
AEP
SRE
PCG
ED
XEL
WEC
EIX
D
PNW
CMS
CEG
NRG
ECL
LIN
APD
DD
DOW
MMM
BA
LMT
RTX
GD
NOC
AVGO
TXN
ADI
NXPI
MRVL
ON
MCHP
ALGN
ISRG
MDT
SYK
ZBH
BAX
EW
TFX
AZN
BNTX
CRSP
EDIT
NTLA
CPRT
AZO
ORLY
LAD
CAR
AVTR
ILMN
DXCM
GOOGL
META
Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight
prnewswire.com
JNJ
GILD
BMY
REGN
ABBV
ADPT
Acute Lymphocytic Leukemia Market: Analysis and Forecast, 2025-2035
globenewswire.com
BMY
NVS
PFE
GILD
MRK
New Study: Integrative Therapy and Nurse Navigation Reduce Treatment Side Effects for 75% of Black Breast Cancer Patients; 85% Report Lower Distress
businesswire.com
AZN
GILD
Global Medical Device Contract Manufacturing Market is Predicted to Cross the USD 190 Billion Mark by 2032, Owing to the Rising Demand for Advanced Healthcare Solutions | DelveInsight
globenewswire.com
TMO
PFE
AMGN
BMY
MRK
DHR
ABBV
GOOG
MSFT
JNJ
MDT
BSX
SYK
EW
ISRG
EMR
BIOX
EXAS
QRVO
TER
ADI
TXN
ON
INTC
NVDA
AMD
HPQ
DELL
IBM
GE
FISV
ADP
PAYX
NOW
CRM
ORCL
SAP
ADSK
CDNS
SNPS
AMAT
INFY
HPE
LOGI
ATHM
BIIB
GILD
REGN
VRTX
AMRN
AZN
LLY
NVS
CRSP
EDIT
NTLA
ALNY
INCY
XRAY
COO
MASI
IRTC
MRNA
EMB
ADMA
ICUI
HOLX
LH
DGX
RDNT
EVTC
AFYA
CHKP
DDOG
SMCI
ALGN
THRY
PTC
MCHP
NXPI
QCOM
SWKS
MU
WDC
STX
Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+ in patients with first line advanced melanoma
globenewswire.com
GILD
BMY